<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_schizophrenia" title="Association of Typical Toxic Heavy Metals with Schizophrenia" shortTitle="schizophrenia" author="Jiahui Ma, Lailai Yan, Tongjun Guo, Siyu Yang, Chen Guo, Yaqiong Liu, Qing Xie, Jingyu Wang" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/1660-4601/16/21/4200/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
1.	LS	1.
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Schizophrenia	NN	Schizophrenia
is	VBZ	be
a	DT	a
severe	JJ	severe
mental	JJ	mental
illness	NN	illness
that	WDT	that
affects	VBZ	affect
about	RB	about
one	CD	one
percent	NN	percent
of	IN	of
the	DT	the
world	NN	world
’s	POS	's
population	NN	population
.	.	.
</s>
<s type="decl">
The	DT	the
patients	NNS	patient
with	IN	with
schizophrenia	NN	schizophrenia
are	VBP	be
characterized	VBN	characterize
with	IN	with
cognitive	JJ	cognitive
impairment	NN	impairment
,	,	,
confusion	NN	confusion
,	,	,
hallucinations	NNS	hallucination
and	CC	and
deterioration	NN	deterioration
of	IN	of
social	JJ	social
function	NN	function
.	.	.
</s>
<s type="decl">
It	PRP	it
is	VBZ	be
noted	VBN	note
that	IN	that
schizophrenia	NN	schizophrenia
leads	VBZ	lead
to	IN	to
a	DT	a
heavy	JJ	heavy
burden	NN	burden
on	IN	on
the	DT	the
patients	NNS	patient
,	,	,
their	PRP$	their
families	NNS	family
and	CC	and
society	NN	society
.	.	.
</s>
<s type="decl">
Substantial	JJ	Substantial
efforts	NNS	effort
have	VBP	have
been	VBN	be
devoted	VBN	devote
to	IN	to
elucidating	VBG	elucidate
the	DT	the
pathophysiology	NN	pathophysiology
of	IN	of
schizophrenia	NN	schizophrenia
development	NN	development
from	IN	from
genetic	JJ	genetic
and	CC	and
environmental	JJ	environmental
perspectives	NNS	perspective
,	,	,
as	RB	as
well	RB	well
as	IN	as
gene-environment	JJ	gene-environment
interactions	NNS	interaction
.	.	.
</s>
<s type="decl">
Epidemiological	JJ	Epidemiological
studies	NNS	study
have	VBP	have
suggested	VBN	suggest
that	IN	that
urban	JJ	urban
environments	NNS	environment
could	MD	could
increase	VB	increase
the	DT	the
risk	NN	risk
of	IN	of
schizophrenia	NN	schizophrenia
,	,	,
which	WDT	which
may	MD	may
be	VB	be
due	JJ	due
to	IN	to
the	DT	the
exposure	NN	exposure
to	IN	to
the	DT	the
toxic	JJ	toxic
heavy	JJ	heavy
metals	NNS	metal
(	-LRB-	(
THMs	NNS	THM
)	-RRB-	)
in	IN	in
the	DT	the
environment	NN	environment
.	.	.
</s>
</p>
<p>
<s type="decl">
Chronic	JJ	Chronic
exposure	NN	exposure
to	IN	to
THMs	NNS	THM
impairs	VBZ	impair
numerous	JJ	numerous
biological	JJ	biological
functions	NNS	function
and	CC	and
results	VBZ	result
in	IN	in
a	DT	a
series	NN	series
of	IN	of
health	NN	health
problems	NNS	problem
,	,	,
such	JJ	such
as	IN	as
aberrant	JJ	aberrant
immunological	JJ	immunological
responses	NNS	response
and	CC	and
neuropathological	JJ	neuropathological
conditions	NNS	condition
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
it	PRP	it
has	VBZ	have
been	VBN	be
reported	VBN	report
that	IN	that
THMs	NNPS	ThM
could	MD	could
cause	VB	cause
oxidative	JJ	oxidative
stress	NN	stress
and	CC	and
subsequently	RB	subsequently
DNA	NN	DNA
damage	NN	damage
,	,	,
lipid	NN	lipid
peroxidation	NN	peroxidation
and	CC	and
protein	NN	protein
modification	NN	modification
,	,	,
which	WDT	which
play	VBP	play
a	DT	a
role	NN	role
in	IN	in
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
numerous	JJ	numerous
diseases	NNS	disease
,	,	,
including	VBG	include
cancer	NN	cancer
,	,	,
diabetes	NN	diabet
,	,	,
neurological	JJ	neurological
disorders	NNS	disorder
and	CC	and
chronic	JJ	chronic
inflammation	NN	inflammation
.	.	.
</s>
<s type="decl">
THMs	NNS	THM
are	VBP	be
suggested	VBN	suggest
as	IN	as
an	DT	a
important	JJ	important
risk	NN	risk
factor	NN	factor
for	IN	for
mental	JJ	mental
diseases	NNS	disease
since	IN	since
they	PRP	they
cause	VBP	cause
neurobehavioral	JJ	neurobehavioral
alterations	NNS	alteration
and	CC	and
disrupt	VBP	disrupt
dopamine	NN	dopamine
receptors	NNS	receptor
.	.	.
</s>
<s type="decl">
For	IN	for
example	NN	example
,	,	,
arsenic	NN	arsenic
(	-LRB-	(
As	IN	as
)	-RRB-	)
-induced	VBN	-induce
neurotoxicity	NN	neurotoxicity
has	VBZ	have
been	VBN	be
reported	VBN	report
to	TO	to
cause	VB	cause
compositional	JJ	compositional
changes	NNS	change
and	CC	and
hyperphosphorylation	NN	hyperphosphorylation
on	IN	on
the	DT	the
cytoskeletal	JJ	cytoskeletal
protein	NN	protein
,	,	,
leading	VBG	lead
to	IN	to
the	DT	the
disintegration	NN	disintegration
of	IN	of
the	DT	the
cytoskeletal	JJ	cytoskeletal
framework	NN	framework
and	CC	and
causing	VBG	cause
neurodegenerative	JJ	neurodegenerative
diseases	NNS	disease
.	.	.
</s>
<s type="decl">
An	DT	a
animal	NN	animal
study	NN	study
showed	VBD	show
lead	NN	lead
(	-LRB-	(
Pb	NN	Pb
)	-RRB-	)
as	IN	as
an	DT	a
environmental	JJ	environmental
toxin	NN	toxin
,	,	,
which	WDT	which
contributed	VBD	contribute
to	IN	to
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
schizophrenia	NN	schizophrenia
in	IN	in
Disrupted-in-Schizophrenia	NNP	Disrupted-in-Schizophrenia
1	CD	1
(	-LRB-	(
Disc1)-mutant	NNP	Disc1)-mutant
mice	NNS	mouse
.	.	.
</s>
<s type="decl">
Therefore	RB	therefore
,	,	,
investigating	VBG	investigate
the	DT	the
association	NN	association
of	IN	of
environmental	JJ	environmental
THM	NNP	THM
exposure	NN	exposure
with	IN	with
the	DT	the
risk	NN	risk
of	IN	of
schizophrenia	NN	schizophrenia
via	IN	via
a	DT	a
reliable	JJ	reliable
epidemiological	JJ	epidemiological
study	NN	study
is	VBZ	be
worthwhile	JJ	worthwhile
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
serum	JJ	serum
concentration	NN	concentration
of	IN	of
THMs	NNS	THM
has	VBZ	have
been	VBN	be
suggested	VBN	suggest
to	TO	to
act	VB	act
as	IN	as
an	DT	a
internal	JJ	internal
indicator	NN	indicator
of	IN	of
their	PRP$	their
intake	NN	intake
levels	NNS	level
,	,	,
reflecting	VBG	reflect
exposure	NN	exposure
to	IN	to
environmental	JJ	environmental
THMs	NNS	THM
.	.	.
</s>
<s type="decl">
Changes	NNS	change
in	IN	in
THM	NNP	THM
concentrations	NNS	concentration
have	VBP	have
been	VBN	be
observed	VBN	observe
in	IN	in
peripheral	JJ	peripheral
tissues	NNS	tissue
to	TO	to
be	VB	be
correlated	VBN	correlate
with	IN	with
the	DT	the
risk	NN	risk
of	IN	of
schizophrenia	NN	schizophrenia
.	.	.
</s>
<s type="decl">
Although	IN	although
multiple	JJ	multiple
studies	NNS	study
have	VBP	have
investigated	VBN	investigate
the	DT	the
association	NN	association
between	IN	between
THMs	NNS	THM
and	CC	and
schizophrenia	NN	schizophrenia
,	,	,
the	DT	the
results	NNS	result
remain	VBP	remain
inconsistent	JJ	inconsistent
.	.	.
</s>
<s type="decl">
For	IN	for
example	NN	example
,	,	,
despite	IN	despite
supporting	VBG	support
evidence	NN	evidence
both	CC	both
in	IN	in
vitro	NN	vitro
and	CC	and
in	IN	in
vivo	NN	vivo
for	IN	for
the	DT	the
association	NN	association
between	IN	between
Pb	NN	Pb
and	CC	and
schizophrenia	NN	schizophrenia
,	,	,
a	DT	a
cross-sectional	JJ	cross-sectional
study	NN	study
among	IN	among
a	DT	a
Chinese	JJ	Chinese
population	NN	population
showed	VBD	show
no	DT	no
significant	JJ	significant
difference	NN	difference
in	IN	in
the	DT	the
concentration	NN	concentration
of	IN	of
Pb	NN	Pb
between	IN	between
patients	NNS	patient
with	IN	with
schizophrenia	NN	schizophrenia
and	CC	and
healthy	JJ	healthy
controls	NNS	control
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
another	DT	another
study	NN	study
applying	VBG	apply
a	DT	a
very	RB	very
similar	JJ	similar
study	NN	study
design	NN	design
towards	IN	towards
the	DT	the
same	JJ	same
sampling	NN	sampling
region	NN	region
resulted	VBD	result
in	IN	in
a	DT	a
significant	JJ	significant
association	NN	association
.	.	.
</s>
<s type="sub">
The	DT	the
reason	NN	reason
for	IN	for
the	DT	the
divergence	NN	divergence
may	MD	may
be	VB	be
related	JJ	related
to	IN	to
the	DT	the
choice	NN	choice
of	IN	of
the	DT	the
population	NN	population
,	,	,
such	JJ	such
as	IN	as
whether	IN	whether
the	DT	the
schizophrenic	JJ	schizophrenic
patients	NNS	patient
have	VBP	have
received	VBN	receive
antipsychotics	NNS	antipsychotics
drug	NN	drug
during	IN	during
the	DT	the
time	NN	time
of	IN	of
study	NN	study
.	.	.
</s>
<s type="decl">
A	DT	a
previous	JJ	previous
study	NN	study
has	VBZ	have
compared	VBN	compare
serum	NN	serum
cadmium	NN	cadmium
(	-LRB-	(
Cd	NN	Cd
)	-RRB-	)
concentration	NN	concentration
between	IN	between
healthy	JJ	healthy
controls	NNS	control
and	CC	and
schizophrenia	NN	schizophrenia
patients	NNS	patient
with	IN	with
or	CC	or
without	IN	without
treatment	NN	treatment
.	.	.
</s>
<s type="decl">
The	DT	the
serum	JJ	serum
concentration	NN	concentration
of	IN	of
Cd	NN	Cd
in	IN	in
patients	NNS	patient
after	IN	after
treatment	NN	treatment
was	VBD	be
significantly	RB	significantly
higher	JJR	high
than	IN	than
that	DT	that
of	IN	of
the	DT	the
healthy	JJ	healthy
controls	NNS	control
but	CC	but
no	DT	no
significant	JJ	significant
change	NN	change
was	VBD	be
observed	VBN	observe
from	IN	from
the	DT	the
pre-treatment	JJ	pre-treatment
patients	NNS	patient
.	.	.
</s>
<s type="decl">
The	DT	the
concentration	NN	concentration
of	IN	of
antimony	NN	antimony
and	CC	and
uranium	NN	uranium
were	VBD	be
also	RB	also
found	VBN	find
significantly	RB	significantly
different	JJ	different
between	IN	between
pre-treatment	JJ	pre-treatment
patients	NNS	patient
and	CC	and
post-treatment	JJ	post-treatment
patients	NNS	patient
of	IN	of
schizophrenia	NN	schizophrenia
.	.	.
</s>
</p>
<p>
<s type="decl">
Although	IN	although
several	JJ	several
studies	NNS	study
have	VBP	have
investigated	VBN	investigate
the	DT	the
association	NN	association
between	IN	between
THMs	NNS	THM
and	CC	and
schizophrenia	NN	schizophrenia
,	,	,
the	DT	the
potential	JJ	potential
mechanisms	NNS	mechanism
which	WDT	which
could	MD	could
link	VB	link
THMs	NNS	THM
and	CC	and
schizophrenia	NN	schizophrenia
have	VBP	have
not	RB	not
been	VBN	be
elucidated	VBN	elucidate
.	.	.
</s>
<s type="decl">
Recent	JJ	Recent
studies	NNS	study
have	VBP	have
suggested	VBN	suggest
metabolic	NN	metabolic
syndrome	NN	syndrome
as	IN	as
a	DT	a
risk	NN	risk
factor	NN	factor
of	IN	of
schizophrenia	NN	schizophrenia
,	,	,
attributed	VBN	attribute
to	IN	to
poor	JJ	poor
dietary	NN	dietary
habits	NNS	habit
,	,	,
unhealthy	JJ	unhealthy
lifestyle	NN	lifestyle
and	CC	and
physical	JJ	physical
inactivity	NN	inactivity
of	IN	of
the	DT	the
patients	NNS	patient
and	CC	and
side-effects	NNS	side-effect
of	IN	of
the	DT	the
second	JJ	second
generation-antipsychotics	NN	generation-antipsychotics
.	.	.
</s>
<s type="decl">
On	IN	on
the	DT	the
other	JJ	other
hand	NN	hand
,	,	,
THMs	NNPS	ThM
such	JJ	such
as	IN	as
As	IN	as
and	CC	and
Pb	NN	Pb
were	VBD	be
found	VBN	find
to	TO	to
be	VB	be
associated	VBN	associate
with	IN	with
metabolic	JJ	metabolic
diseases	NNS	disease
,	,	,
suggesting	VBG	suggest
a	DT	a
role	NN	role
of	IN	of
abnormal	JJ	abnormal
metabolisms	NNS	metabolism
in	IN	in
linking	VBG	link
THMs	NNS	THM
and	CC	and
schizophrenia	NN	schizophrenia
.	.	.
</s>
</p>
<p>
<s type="decl">
Therefore	RB	therefore
,	,	,
we	PRP	we
performed	VBD	perform
a	DT	a
case-control	JJ	case-control
study	NN	study
with	IN	with
first-episode	JJ	first-episode
and	CC	and
drug-naïve	JJ	drug-naïve
schizophrenia	NN	schizophrenia
patients	NNS	patient
and	CC	and
healthy	JJ	healthy
controls	NNS	control
to	TO	to
identify	VB	identify
the	DT	the
association	NN	association
between	IN	between
serum	NN	serum
concentrations	NNS	concentration
of	IN	of
the	DT	the
4	CD	4
THMs	NNS	THM
(	-LRB-	(
i.e.	FW	i.e.
,	,	,
Cr	NNP	Cr
,	,	,
Cd	NNP	Cd
,	,	,
Pb	NNP	Pb
and	CC	and
As	NNPS	as
,	,	,
selected	VBN	select
as	IN	as
commonly	RB	commonly
surveyed	VBN	survey
heavy	JJ	heavy
metals	NNS	metal
in	IN	in
schizophrenia	NN	schizophrenia
studies	NNS	study
)	-RRB-	)
and	CC	and
the	DT	the
risk	NN	risk
of	IN	of
schizophrenia	NN	schizophrenia
.	.	.
</s>
<s type="decl">
The	DT	the
correlations	NNS	correlation
between	IN	between
the	DT	the
4	CD	4
THMs	NNS	THM
and	CC	and
multiple	JJ	multiple
metabolic	JJ	metabolic
biomarkers	NNS	biomarker
were	VBD	be
also	RB	also
tested	VBN	test
to	TO	to
explore	VB	explore
the	DT	the
potential	JJ	potential
metabolisms	NNS	metabolism
associated	VBN	associate
between	IN	between
these	DT	this
THMs	NNS	THM
and	CC	and
schizophrenia	NN	schizophrenia
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
meta-analysis	NN	meta-analysis
was	VBD	be
conducted	VBN	conduct
to	TO	to
comprehensively	RB	comprehensively
summarize	VB	summarize
the	DT	the
association	NN	association
between	IN	between
the	DT	the
4	CD	4
individual	JJ	individual
THMs	NNS	THM
and	CC	and
the	DT	the
risk	NN	risk
of	IN	of
schizophrenia	NN	schizophrenia
.	.	.
</s>
</p>
</text>